Cargando…

Graft-Versus-Host Disease–Free Antitumoral Signature After Allogeneic Donor Lymphocyte Injection Identified by Proteomics and Systems Biology

PURPOSE: As a tumor immunotherapy, allogeneic hematopoietic cell transplantation with subsequent donor lymphocyte injection (DLI) aims to induce the graft-versus-tumor (GVT) effect but often also leads to acute graft-versus-host disease (GVHD). Plasma tests that can predict the likelihood of GVT wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xiaowen, Yue, Zongliang, Cao, Yimou, Taylor, Lauren, Zhang, Qing, Choi, Sung W., Hanash, Samir, Ito, Sawa, Chen, Jake Y., Wu, Huanmei, Paczesny, Sophie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Clinical Oncology 2019
Materias:	Original Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690359/ https://www.ncbi.nlm.nih.gov/pubmed/31406955 http://dx.doi.org/10.1200/PO.18.00365

Ejemplares similares

A Nasal Inflammatory Cytokine Signature Is Associated with Early Graft-versus-Host Disease of the Lung after Allogeneic Hematopoietic Cell Transplantation: Proof of Concept
por: Ostrin, Edwin J., et al.
Publicado: (2023)

Assessing Donor Liver Quality and Restoring Graft Function in the Era of Extended Criteria Donors
por: Lin, Yimou, et al.
Publicado: (2023)

Combination of anti‐CD4 antibody treatment and donor lymphocyte infusion ameliorates graft‐versus‐host disease while preserving graft‐versus‐tumor effects in murine allogeneic hematopoietic stem cell transplantation
por: Ueha, Satoshi, et al.
Publicado: (2017)

Harnessing allogeneic NK cells: improving outcomes with tailored donor lymphocyte infusion
por: McCurdy, Shannon R.
Publicado: (2022)

Biomarkers for Allogeneic HCT Outcomes
por: Adom, Djamilatou, et al.
Publicado: (2020)

A Proteomic Approach to the Identification of Lung Cancer Markers
por: Hanash, Samir, et al.
Publicado: (2001)

Prolonged Survival of Subcutaneous Allogeneic Islet Graft by Donor Chimerism without Immunosuppressive Treatment
por: Hsu, Brend Ray-Sea, et al.
Publicado: (2017)

Immunomodulation with dendritic cells and donor lymphocyte infusion converge to induce graft vs neuroblastoma reactions without GVHD after allogeneic bone marrow transplantation
por: Ash, S, et al.
Publicado: (2010)

Proteomics Approaches to Identify Tumor Antigen Directed Autoantibodies as Cancer Biomarkers
por: Imafuku, Yuji, et al.
Publicado: (2004)

The graft-versus-leukemia effect of prophylactic donor lymphocyte infusions after allogeneic stem cell transplantation is equally effective in relapse prevention but safer compared to spontaneous graft-versus-host disease
por: Stadler, Michael, et al.
Publicado: (2023)

Effects of decitabine on allogeneic immune reactions of donor lymphocyte infusion via activation of dendritic cells
por: Kwon, Yong-Rim, et al.
Publicado: (2020)

Donor Bone Marrow-Derived T Cells Inhibit GVHD Induced by Donor Lymphocyte Infusion in Established Mixed Allogeneic Hematopoietic Chimeras
por: Wang, Hui, et al.
Publicado: (2012)

Preimmunization of donor lymphocytes enhances antitumor immunity of autologous hematopoietic stem cell transplantation
por: Suzuki, Koji, et al.
Publicado: (2013)

Durable Remission of Renal Cell Carcinoma in Conjuncture with Graft versus Host Disease following Allogeneic Stem Cell Transplantation and Donor Lymphocyte Infusion: Rule or Exception?
por: van Bergen, Cornelis A. M., et al.
Publicado: (2014)

High-throughput genomic technology in research and clinical management of breast cancer. Plasma-based proteomics in early detection and therapy
por: Davis, Michael A, et al.
Publicado: (2006)

Allogeneic lymphocyte-licensed DCs expand T cells with improved antitumor activity and resistance to oxidative stress and immunosuppressive factors
por: Jin, Chuan, et al.
Publicado: (2014)

Sendai virus-specific, H-2-restricted cytotoxic T lymphocyte responses of nude mice grafted with allogeneic or semi-allogeneic thymus glands
Publicado: (1980)

MRD as Biomarker for Response to Donor Lymphocyte Infusion after Allogeneic Hematopoietic Cell Transplantation in Patients with AML
por: Teich, Katrin, et al.
Publicado: (2023)

T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor
por: Jiang, Hua, et al.
Publicado: (2021)

Graft‐versus‐mastocytosis effect after donor lymphocyte infusion: Proof of principle
por: Hägglund, Hans, et al.
Publicado: (2020)

High-Definition Mapping of Retroviral Integration Sites Defines the Fate of Allogeneic T Cells After Donor Lymphocyte Infusion
por: Cattoglio, Claudia, et al.
Publicado: (2010)

Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donors
por: Liberatore, Carmine, et al.
Publicado: (2022)

Long-term viability of allogenic donor stroma
por: Carpel, Emmett F, et al.
Publicado: (2020)

Towards an integrated proteomic and glycomic approach to finding cancer biomarkers
por: Taylor, Allen D, et al.
Publicado: (2009)

A biomarker signature to predict complete response to itacitinib and corticosteroids in acute graft‐versus‐host disease
por: Pratta, Michael, et al.
Publicado: (2022)

Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans
Publicado: (1993)

Attenuation of Hepatic Graft-versus-host Disease in Allogeneic Recipients of MyD88-deficient Donor Bone Marrow
por: Lim, Ji-Young, et al.
Publicado: (2015)

Allogeneic Transplantation for Chronic Lymphocytic Leukemia
por: Laurenti, Luca, et al.
Publicado: (2010)

P1365: DONOR LYMPHOCYTE INFUSION IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: RESULTS FROM A RETROSPECTIVE STUDY
por: Rochate, D., et al.
Publicado: (2022)

Combination of Donor Lymphocyte Infusion and Blinatumomab for B-Cell Lymphoblastic Lymphoma Relapse after Allogeneic Stem-Cell Transplantation
por: Mori, Jinichi, et al.
Publicado: (2023)

THE ALLOGENEIC EFFECT IN INBRED MICE : IV. REGULATORY INFLUENCES OF GRAFT-VS.-HOST REACTIONS ON HOST T LYMPHOCYTE FUNCTIONS
por: Osborne, David P., et al.
Publicado: (1973)

Application of serum proteomics to the Women's Health Initiative conjugated equine estrogens trial reveals a multitude of effects relevant to clinical findings
por: Katayama, Hiroyuki, et al.
Publicado: (2009)

Global Strategies for Disease Detection and Treatment: Proteomics
por: Srivastava, Sudhir, et al.
Publicado: (2001)

The emergence of WT1-specific T-cell responses following allogeneic T cell-depleted hematopoietic stem cell transplantation and low-dose donor lymphocyte infusions is associated with a graft-vs.- myeloma effect
por: Tyler, Eleanor M, et al.
Publicado: (2013)

Tumor-specific donor lymphocyte infusion therapy with allogeneic T cells utilizing novel retrovirus vector silencing endogenous TCR expression
por: Ikeda, Hiroaki, et al.
Publicado: (2014)

Lymphodepleting chemotherapy with donor lymphocyte infusion post-allogeneic HCT for hematological malignancies is associated with severe, but therapy-responsive aGVHD
por: He, Fiona, et al.
Publicado: (2016)

An Experience of Donor Lymphocyte Infusion after Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease
por: Rostami, Tahereh, et al.
Publicado: (2020)

A Phase I Trial of Allogeneic γδ T Lymphocytes From Haploidentical Donors in Patients With Refractory or Relapsed Acute Myeloid Leukemia
por: Vydra, Jan, et al.
Publicado: (2023)

Proteome Profiling Uncovers an Autoimmune Response Signature That Reflects Ovarian Cancer Pathogenesis
por: Kobayashi, Makoto, et al.
Publicado: (2020)

iTRAQ-Based Proteomic Analysis of Polyploid Giant Cancer Cells and Budding Progeny Cells Reveals Several Distinct Pathways for Ovarian Cancer Development
por: Zhang, Shiwu, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_b3hfrc46a59l46q55hv7i1pah7